ES353413A1 - Procedimiento para la obtencion de composiciones para com- batir la coccidiosis en los pollos. - Google Patents

Procedimiento para la obtencion de composiciones para com- batir la coccidiosis en los pollos.

Info

Publication number
ES353413A1
ES353413A1 ES353413A ES353413A ES353413A1 ES 353413 A1 ES353413 A1 ES 353413A1 ES 353413 A ES353413 A ES 353413A ES 353413 A ES353413 A ES 353413A ES 353413 A1 ES353413 A1 ES 353413A1
Authority
ES
Spain
Prior art keywords
saturated
group
unsaturated
coccidiosis
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES353413A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
May and Baker Ltd
Original Assignee
May and Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May and Baker Ltd filed Critical May and Baker Ltd
Publication of ES353413A1 publication Critical patent/ES353413A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES353413A 1967-05-02 1968-05-02 Procedimiento para la obtencion de composiciones para com- batir la coccidiosis en los pollos. Expired ES353413A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB20400/67A GB1188364A (en) 1967-05-02 1967-05-02 Quinoline Derivatives

Publications (1)

Publication Number Publication Date
ES353413A1 true ES353413A1 (es) 1970-01-16

Family

ID=10145349

Family Applications (1)

Application Number Title Priority Date Filing Date
ES353413A Expired ES353413A1 (es) 1967-05-02 1968-05-02 Procedimiento para la obtencion de composiciones para com- batir la coccidiosis en los pollos.

Country Status (6)

Country Link
CH (1) CH487158A (fr)
DE (1) DE1770317A1 (fr)
ES (1) ES353413A1 (fr)
FR (2) FR1584259A (fr)
GB (1) GB1188364A (fr)
IT (1) IT1056722B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH590236A5 (fr) * 1973-07-03 1977-07-29 Ciba Geigy Ag
US5283352A (en) * 1986-11-28 1994-02-01 Orion-Yhtyma Oy Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same
YU213587A (en) * 1986-11-28 1989-06-30 Orion Yhtymae Oy Process for obtaining new pharmacologic active cateholic derivatives
FI864875A0 (fi) * 1986-11-28 1986-11-28 Orion Yhtymae Oy Nya farmakologiskt aktiva foereningar, dessa innehaollande kompositioner samt foerfarande och mellanprodukter foer anvaendning vid framstaellning av dessa.
US5489614A (en) * 1987-11-27 1996-02-06 Orion-Yhtyma Oy Catechol derivatives, their physiologically acceptable salts, esters and use
MTP1031B (en) * 1987-12-24 1990-10-04 Orion Yhtymae Oy New use of cathecol-o-methyl transferase (comt) inhibitors and their physiologically acceptable salts and esters
GB9010394D0 (en) * 1990-05-09 1990-06-27 Ici Plc Heterocyclic compounds

Also Published As

Publication number Publication date
FR7611M (fr) 1970-01-19
CH487158A (fr) 1970-03-15
DE1770317A1 (de) 1971-10-07
IT1056722B (it) 1982-02-20
FR1584259A (fr) 1969-12-19
GB1188364A (en) 1970-04-15

Similar Documents

Publication Publication Date Title
ES353413A1 (es) Procedimiento para la obtencion de composiciones para com- batir la coccidiosis en los pollos.
GB1142066A (en) New diphenyl-ureas and process for preparing them
GB1153366A (en) Substituted Benzoic Acid Lactones having Estrogenic Properties
ES368955A1 (es) Procedimiento para preparar guanidinas sustituidas
ES353521A1 (es) Procedimiento para la obtencion de composiciones para com- batir la coccidiosis en los pollos.
DE2963545D1 (en) Pharmaceutical composition containing all-e- or 13-z-7,8-dehydro-retinoic acid and process for its preparation
GB1314952A (en) 3,4,5-trialkoxy-benzoic acid derivatives and their uses
GB1322112A (en) 3,4,5-trimethoxybenzoic acid derivatives and their uses
ES351083A1 (es) Procedimiento para la preparacion de derivados de quinoli- na.
ES2005165A6 (es) Procedimiento de preparacion del complejo de cincl de 5-cloro-7-yodo-8-hidroxi-quinolina
GB1416705A (en) Keto-esters
GB1152637A (en) Veterinary Compositions
ES338660A1 (es) Procedimiento de preparacion de nuevas cloroquinoleinas.
GB1172841A (en) 4-Acyloxy Quinoline Derivatives, Process for their Manufacture, and their use as Coccidiostats
GB1158954A (en) N-(4-Carboxy-Phenyl)-Anthranilic Acid, derivatives thereof and a process for their preparation
ES342394A1 (es) Procedimiento para la produccion de nuevas 2-bencilamino-i-mida-zolinas-(2).
GB1464082A (en) Pharmaceutical 'ompositions containing benzylamines
GB1097938A (en) Therapeutic compositions containing penicillin derivatives
GB1313838A (en) 3,4,5-trialkoxybenzoic acid derivatives and their uses
GB1211387A (en) 0-benzylpiperidine derivative and a process for the preparation thereof
GB1173636A (en) Alkyl Phenylpiperazinylalkylcarbamates
ES369646A1 (es) Un procedimiento de preparacion de los derivados de acido 5-tiazol carboxilico.
GB1078745A (en) Composition and process for inhibiting egg-production in birds
GB1175169A (en) Tryptamine Compounds
GB905197A (en) Anti-viral compositions comprising 1-phenyl-2-amino-propane-1,3-diol derivatives